Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Veeva Systems Acquires AdvantageMS

Published: Wednesday, June 26, 2013
Last Updated: Wednesday, June 26, 2013
Bookmark and Share
Acquisition enhances Veeva Network – a complete, cloud-based customer master solution.

Following Veeva Systems’ recent unveiling of Veeva Network, the life sciences industry’s first cloud-based customer master solution, the company has acquired national healthcare data provider, AdvantageMS. The acquisition adds a database of more than seven million active healthcare providers (HCPs), healthcare organizations (HCOs) and affiliations across the United States to Veeva Network. This acquired data, combined with Veeva’s advanced cloud software and data stewardship services, provides life sciences companies with an accurate, up-to-date view of their customers in one solution.

Historically, life sciences organizations have struggled to stitch together sets of non-standardized data from a myriad of sources. Generating a single source of the truth about customers that’s accurate, kept up-to-date and accessible to users has proven to be expensive, time consuming and yet still elusive for most. With Veeva’s acquisition of AdvantageMS, Veeva Network will provide pharmaceutical companies with accurate information on their customers without the complicated patchwork of systems, data and staff. Additionally, Veeva Network is integrated with Veeva CRM, so data is fully accessible to sales and marketing users for improved efficiency.

“AdvantageMS is an organization of great people and their data is one of the most reliable sources of U.S. healthcare data, trusted by life sciences organizations of all sizes for over a decade,” said Peter Gassner, president and CEO of Veeva Systems. “We are thrilled to have AdvantageMS join the Veeva team.”

AdvantageMS also provides Veeva Network with data compliance services and one of the most detailed HCP email lists available, with over 500,000 verified records. The database is 100% permission-based and contains workplace email addresses, including hard-to-find group practice and hospital-based emails. As a result, life sciences companies will be able to reliably extend their digital outreach programs.

“Like AdvantageMS, Veeva is dedicated to customer success. By combining our data and services with the Veeva Network application we will deliver exceptional value to our joint customers,” explained Richard Johnston, CEO of AdvantageMS.

AdvantageMS customers will continue to receive existing data services, while joint Veeva and AdvantageMS customers will be able to benefit from the strategic acquisition through Veeva Network – planned for general availability throughout the United States and China in late 2013, with other markets to follow.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!